BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28835677)

  • 1. Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice.
    Camps G; Maestro S; Torella L; Herrero D; Usai C; Bilbao-Arribas M; Aldaz A; Olagüe C; Vales A; Suárez-Amarán L; Aldabe R; Gonzalez-Aseguinolaza G
    PLoS Pathog; 2024 May; 20(5):e1011749. PubMed ID: 38739648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPK1 protects naive and regulatory T cells from TNFR1-induced apoptosis.
    Huysentruyt J; Steels W; Ruiz Perez M; Verstraeten B; Vadi M; Divert T; Flies K; Takahashi N; Lambrecht BN; Declercq W; Vanden Berghe T; Maelfait J; Vandenabeele P; Tougaard P
    Cell Death Differ; 2024 May; ():. PubMed ID: 38734851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enigma of RIPK1 in the liver: More than just a kinase.
    Vucur M; Schneider AT; Gautheron J; Luedde T
    Mol Cell Oncol; 2017; 4(3):e1304191. PubMed ID: 28616581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.
    Geng J; Ito Y; Shi L; Amin P; Chu J; Ouchida AT; Mookhtiar AK; Zhao H; Xu D; Shan B; Najafov A; Gao G; Akira S; Yuan J
    Nat Commun; 2017 Aug; 8(1):359. PubMed ID: 28842570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense.
    Peterson LW; Philip NH; DeLaney A; Wynosky-Dolfi MA; Asklof K; Gray F; Choa R; Bjanes E; Buza EL; Hu B; Dillon CP; Green DR; Berger SB; Gough PJ; Bertin J; Brodsky IE
    J Exp Med; 2017 Nov; 214(11):3171-3182. PubMed ID: 28855241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological events and molecular signaling following MLKL activation during necroptosis.
    Gong YN; Guy C; Crawford JC; Green DR
    Cell Cycle; 2017 Oct; 16(19):1748-1760. PubMed ID: 28854080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thioredoxin-1 actively maintains the pseudokinase MLKL in a reduced state to suppress disulfide bond-dependent MLKL polymer formation and necroptosis.
    Reynoso E; Liu H; Li L; Yuan AL; Chen S; Wang Z
    J Biol Chem; 2017 Oct; 292(42):17514-17524. PubMed ID: 28878015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytoplasmic nuclear receptor RARγ controls RIP1 initiated cell death when cIAP activity is inhibited.
    Xu Q; Jitkaew S; Choksi S; Kadigamuwa C; Qu J; Choe M; Jang J; Liu C; Liu ZG
    Nat Commun; 2017 Sep; 8(1):425. PubMed ID: 28871172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma regulates inflammatory cell death by targeting necroptosis in experimental autoimmune arthritis.
    Lee SH; Kwon JY; Kim SY; Jung K; Cho ML
    Sci Rep; 2017 Aug; 7(1):10133. PubMed ID: 28860618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRE1 RNase controls CD95-mediated cell death.
    Pelizzari-Raymundo D; Maltret V; Nivet M; Pineau R; Papaioannou A; Zhou X; Caradec F; Martin S; Le Gallo M; Avril T; Chevet E; Lafont E
    EMBO Rep; 2024 Apr; 25(4):1792-1813. PubMed ID: 38383861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RIPK1 in Liver Parenchymal Cells Limits Murine Hepatitis during Acute CCl
    Hameed H; Farooq M; Vuillier C; Piquet-Pellorce C; Hamon A; Dimanche-Boitrel MT; Samson M; Le Seyec J
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-interacting protein kinase-1 ablation in liver parenchymal cells promotes liver fibrosis in murine NASH without affecting other symptoms.
    Farooq M; Simoes Eugénio M; Piquet-Pellorce C; Dion S; Raguenes-Nicol C; Santamaria K; Kara-Ali GH; Larcher T; Dimanche-Boitrel MT; Samson M; Le Seyec J
    J Mol Med (Berl); 2022 Jul; 100(7):1027-1038. PubMed ID: 35476028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIPK3: A New Player in Renal Fibrosis.
    Shi Y; Chen X; Huang C; Pollock C
    Front Cell Dev Biol; 2020; 8():502. PubMed ID: 32613000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necroptotic Cell Death in Liver Transplantation and Underlying Diseases: Mechanisms and Clinical Perspective.
    Shi S; Verstegen MMA; Mezzanotte L; de Jonge J; Löwik CWGM; van der Laan LJW
    Liver Transpl; 2019 Jul; 25(7):1091-1104. PubMed ID: 31077562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIPK1 protects hepatocytes from death in Fas-induced hepatitis.
    Filliol A; Farooq M; Piquet-Pellorce C; Genet V; Dimanche-Boitrel MT; Vandenabeele P; Bertrand MJM; Samson M; Le Seyec J
    Sci Rep; 2017 Aug; 7(1):9205. PubMed ID: 28835677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis.
    Filliol A; Piquet-Pellorce C; Raguénès-Nicol C; Dion S; Farooq M; Lucas-Clerc C; Vandenabeele P; Bertrand MJM; Le Seyec J; Samson M
    J Hepatol; 2017 Jun; 66(6):1205-1213. PubMed ID: 28088582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis.
    Farooq M; Filliol A; Simoes Eugénio M; Piquet-Pellorce C; Dion S; Raguenes-Nicol C; Jan A; Dimanche-Boitrel MT; Le Seyec J; Samson M
    Cell Death Dis; 2019 Jan; 10(1):12. PubMed ID: 30622241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIPK1 protects from TNF-α-mediated liver damage during hepatitis.
    Filliol A; Piquet-Pellorce C; Le Seyec J; Farooq M; Genet V; Lucas-Clerc C; Bertin J; Gough PJ; Dimanche-Boitrel MT; Vandenabeele P; Bertrand MJ; Samson M
    Cell Death Dis; 2016 Nov; 7(11):e2462. PubMed ID: 27831558
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.